Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Joseph Dowling
Recent news which mentions Joseph Dowling
CV Sciences Q3: Revenue Stable Amid New Launches, Financing
November 14, 2024
Tickers
CVSI
HEMP
Tags
Cannabis
Market News
Joseph Dowling
From
Benzinga
Hemp-Focused CV Sciences Reports Flat Revenue And Over 8% YoY Increase In Gross Profit In Q2
August 13, 2024
Tickers
CVSI
NEWS
Tags
financial statements
Cannabis
Market News
From
Benzinga
Hemp-Focused CV Sciences Reports Steady Q1 Revenue Amid Operational Hurdles And Acquisition Of Nutraceuticals Manufacturer
May 14, 2024
Tickers
CVSI
HEMP
Tags
Elevated Softgels
Nutraceuticals
Earnings
From
Benzinga
Hemp-Focused Wellness Co. Moves Closer To Profitability, Reports Flat 2023 Revenue, Increase In Gross Profit
March 28, 2024
Tickers
CVSI
HEMP
NEWS
Tags
Earnings
Cannabis Earnings
Hemp
From
Benzinga
Capitalizing On Plant-Based Trend: Cultured Foods Acquisition Allows This US Hemp Co. To Expand In Europe
December 12, 2023
Tickers
CVSI
HEMP
Tags
Benzinga
CVSI
Cannabis
From
Benzinga
Hemp-Focused Wellness Company: Revenue Jumps To $4.1M, Gross Margin Peaks At 45.1%
November 14, 2023
Tickers
CVSI
Tags
Markets
Cannabis
Market News
From
Benzinga
Publicly Traded Hemp-Focused Wellness Company Reports Q2 Results, Here Is What You Need To Know
August 14, 2023
Tickers
CVSI
Tags
Benzinga
premium
CVSI
From
Benzinga
CV Sciences Inc Q1 Revenue Stagnates YoY, Here Is What You Need To Know
May 15, 2023
Tickers
CVSI
Tags
Benzinga
CV Sciences Inc/
CVSI
From
Benzinga
CV Sciences FY22 Revenue Declines 19% To $16.2M
March 29, 2023
Tickers
CVSI
Tags
premium
Benzinga
CVSI
From
Benzinga
CBD And Nicotine Formula To Treat Smokeless Tobacco Addiction Receives Patent From Japan, FDA Approval Next
March 23, 2023
Tickers
CVSI
Tags
News
Cannabis
Markets
From
Benzinga
Why Is CV Sciences Stock Up Today?
November 14, 2022
Tickers
CVSI
Tags
Cannabis
Markets
Market News
From
Benzinga
CV Sciences Q1 Revenue Down 8.33%, CEO Encouraged As PlusCBD Brand Gains Market Share
May 16, 2022
Tickers
CVSI
Tags
Benzinga
CVSI
Penny Stocks
From
Benzinga
CV Sciences Adds +PlusCBD Relief Softgels To Wellness Line Of CBD Products
March 08, 2022
Tickers
CVSI
Tags
Markets
Cannabis
Market News
From
Benzinga
CV Sciences Launches +PlusCBD Pain Relief Topicals With Products For Athletes, Arthritis Patients
January 11, 2022
Tickers
CVSI
Tags
CBD for Arthritis Patients
Benzinga
Penny Stocks
From
Benzinga
CV Sciences 3Q Financials Continue To Improve Cost Structure, Praises California CBD Legislation
November 15, 2021
Tickers
CVSI
Tags
Markets
Cannabis
Politics
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.